NCT02995655 2019-12-05
CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
Washington University School of Medicine
Phase 1 Completed
Washington University School of Medicine
New York Medical College